Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 10:51 am Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,715,152 6.630% | 165,090 (+3.63%) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | ProQR Therapeutics N.V. PRQR | FMR LLC | 4,462,438 6.271% | 4,224,522 (+1775.64%) | Filing History |
| 2022-02-07 1:57 pm Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | GOLDMAN SACHS GROUP INC GS | 3,973,650 5.600% | 467,286 (+13.33%) | Filing History |
| 2022-02-04 4:58 pm Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Stichting Aescap Life Sciences | 4,827,372 6.800% | 1,623,176 (+50.66%) | Filing History |
| 2022-02-04 09:12 am Purchase | 2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Wellington Management Group LLP | 4,017,760 5.650% | 561,995 (+16.26%) | Filing History |
| 2021-09-10 1:03 pm Purchase | 2021-09-03 | 13G | ProQR Therapeutics N.V. PRQR | ELI LILLY & Co LLY | 3,989,976 5.600% | 3,989,976 (New Position) | Filing History |
| 2021-04-05 6:26 pm Purchase | 2021-02-01 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 5,088,493 10.100% | 78,725 (+1.57%) | Filing History |
| 2021-02-12 1:02 pm Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | GOLDMAN SACHS & CO. LLC | 3,297,270 6.600% | 3,297,270 (New Position) | Filing History |
| 2021-02-12 09:32 am Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 5,009,768 9.260% | 230,633 (+4.83%) | Filing History |
| 2021-02-11 07:51 am Sale | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,550,062 8.410% | -21,257 (-0.47%) | Filing History |
| 2021-02-10 3:12 pm Sale | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Jennison Associates LLC | 2,616,473 4.800% | -14,153 (-0.54%) | Filing History |
| 2021-02-09 5:00 pm Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Stichting Aescap Life Sciences | 3,204,196 6.400% | 3,204,196 (New Position) | Filing History |
| 2021-02-09 1:02 pm Sale | 2021-02-09 | 13G | ProQR Therapeutics N.V. PRQR | PRUDENTIAL FINANCIAL INC PRU | 2,616,473 4.840% | -14,153 (-0.54%) | Filing History |
| 2021-02-03 1:22 pm Sale | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | Wellington Management Group LLP | 3,455,765 6.390% | -2,039,363 (-37.11%) | Filing History |